Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.65 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.65 |
| ▸ | DHFR | P00374 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 6/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | XBP1 | P17861 | 1/20 | 0.38 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.38 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.38 |
| ▸ | CCR4 | P51679 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29375514 | 0.83 | ESR1 (0.71) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL1324119 | 0.83 | ESR1 (0.71) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL18855333 | 0.81 | ESR1 (0.54) | ESR1ESR2DHFRMEN1KMT2A | |
| SCHEMBL31296636 | 0.79 | ESR1 (0.65) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL1482551 | 0.79 | ESR1 (0.65) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL70957 | 0.79 | ESR1 (1.00) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL31220287 | 0.79 | ESR1 (0.65) | ESR1ESR2MEN1KMT2ALMNA | |
| SCHEMBL217779 | 0.79 | ESR1 (0.65) | ESR1ESR2DHFRMEN1KMT2A | |
| SCHEMBL29850833 | 0.79 | ESR2 (0.65) | ESR1ESR2DHFRMEN1KMT2A | |
| SCHEMBL2832176 | 0.79 | ESR1 (0.65) | ESR1ESR2DHFRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11214583-B2 | Compound having alkoxysilyl group and active ester group, method for preparing same, composition comprising same, and use | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2022-01-04 | — | — | US | disclosed |
| US-20200165275-A1 | COMPOUND HAVING ALKOXYSILYL GROUP AND ACTIVE ESTER GROUP, METHOD FOR PREPARING SAME, COMPOSITION COMPRISING SAME, AND USE | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2020-05-28 | — | — | US | disclosed |
| US-9896535-B2 | Epoxy compound having alkoxysilyl group, method of preparing the same, composition and cured product comprising the same, and uses thereof | KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) | 2018-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200165275-A1 | COMPOUND HAVING ALKOXYSILYL GROUP AND ACTIVE ESTER GROUP, METHOD FOR PREPARING SAME, COMPOSITION COMPRISING SAME, AND USE | NOTUM, AGPS, ESD | ESR1 1248/4885ESR2 2607/4885DHFR 1473/4885 |
| US-11214583-B2 | Compound having alkoxysilyl group and active ester group, method for preparing same, composition comprising same, and use | NOTUM, AGPS, ESD | ESR1 1248/4885ESR2 2607/4885DHFR 1473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.